Skip to main content

Journal of Cardiovascular Translational Research

Ausgabe 6/2022

Inhalt (24 Artikel)

Editorial

DUSP7: an Unusual Player in Adverse Cardiac Remodeling

Gui-e Xu, Jiaxin Song, Priyanka Gokulnath, Gururaja Vulugundam, Junjie Xiao

Original Article

Functional Impact and Regulation of Alternative Splicing in Mouse Heart Development and Disease

Carlos Martí-Gómez, Javier Larrasa-Alonso, Marina López-Olañeta, María Villalba-Orero, Pablo García-Pavía, Fátima Sánchez-Cabo, Enrique Lara-Pezzi

Original Article

Chaetocin attenuates atherosclerosis progression and inhibits vascular smooth muscle cell phenotype switching

Ming-Yun Chen, Zhi-Hui Zhang, Jiang-Feng Ke, Ting-Ting Li, Mei-Fang Li, Jun-Xi Lu, Lian-Xi Li

Review

The Role of ADAM17 in Inflammation-Related Atherosclerosis

Bai-Yi Tang, Jin Ge, Yang Wu, Juan Wen, Xiao-Hong Tang

Original Article

CD137-CD137L Aggravates Calcification of Vascular Smooth Muscle Cell and Vasculature of ApoE−/− Mice Via Rab7-Mediated Autophagy

Ping Yang, Guangyao Zang, Yang Yan, Wei Zhong, Bo Li, Yao Xu, Chen Shao, Zhongqun Wang, Jun Pu, Wei Yuan

Original Article

CircHIPK3 Regulates Vascular Smooth Muscle Cell Calcification Via the miR-106a-5p/MFN2 Axis

Wen-Bo Zhang, You-Fei Qi, Zhan-Xiang Xiao, Hao Chen, Sa-Hua Liu, Zhen-Zhen Li, Zhao-Fan Zeng, Hong-Fei Wu

Original Article

Dickkopf1 (Dkk1) Alleviates Vascular Calcification by Regulating the Degradation of Phospholipase D1 (PLD1)

Xuan Li, Xiao-lin Liu, Xiao Li, Ya-chao Zhao, Qian-qian Wang, Hong-yu Zhong, Dong-dong Liu, Chong Yuan, Teng-fei Zheng, Mei Zhang

Original Article

Calcitriol Supplementation Protects Against Apoptosis and Alleviates the Severity of Abdominal Aortic Aneurysm Induced by Angiotensin II and Anti-TGFβ

Afaf Jreije, Myrna Medlej-Hashim, Joelle Hajal, Youakim Saliba, Stephanie Chacar, Nassim Fares, Lara Khouzami

Original Article

TJ-M2010-5 Attenuates Severe Myocardial Ischemia/Reperfusion Injury in Heart Transplantation by Inhibiting MyD88 Homodimerization In Vivo

Huifang Yang, Ping Zhou, Qingwen Li, Xi Zhou, Junbo Li, Jin Wang, Jingzeng Wang, Yuanyuan Zhao, Bo Yang, Bo Zhang, Chen Dai, Zhimiao Zou, Yang Yang, Zhishui Chen

Original Article

The Role of the Association Between Serum C-Reactive Protein Levels and Coronary Plaque Macrophage Accumulation in Predicting Clinical Events — Results from the CLIMA Registry

Simone Budassi, Flavio Giuseppe Biccirè, Giulia Paoletti, Valeria Marco, Alberto Boi, Enrico Romagnoli, Franco Fabbiocchi, Massimo Fineschi, Riccardo Di Pietro, Francesco Versaci, Giuseppe Calligaris, Laura Gatto, Mario Albertucci, Vito Ramazzotti, Francesco Burzotta, Yukio Ozaki, Eloisa Arbustini, Fernando Alfonso, Francesco Prati

Original Article

Performance of the ABCD-GENE Score for Predicting Clinical Outcomes in Clopidogrel-Treated Patients with ACS

Ying Jin, Jing Ma, Ziqian Wang, Yuting Zou, Guanyun Wang, Yangxun Wu, Yuyan Wang, Haiping Liu, Tong Yin, Ping Ye

Original Article

Circulating exosome-derived miR-122-5p is a novel biomarker for prediction of postoperative atrial fibrillation

Chen Bai, Yisi Liu, Yichen Zhao, Qing Ye, Cheng Zhao, Yang Liu, Jiangang Wang

Original Article

Serum miRNA-203 as a Novel Biomarker for the Early Prediction of Acute ST-elevation Myocardial Infarction

Jun Li, Na Wang, Xiang Wen, Lu-Yao Huang, Rui-Qing Cui, Jing Zhang

Original Article

Pentraxin 3 in Circulating Microvesicles: a Potential Biomarker for Acute Heart Failure After Cardiac Surgery with Cardiopulmonary Bypass

Yuan-Kai Song, Hao-Xiang Yuan, Yu-Peng Jian, Ya-Ting Chen, Kai-Feng Liang, Xiao-Jun Liu, Zhi-Jun Ou, Jia-Sheng Liu, Yan Li, Jing-Song Ou

Original Article

Impact of Pharmacist-Led Heart Failure Clinic on Optimization of Guideline-Directed Medical Therapy (PHARM-HF)

Tanvi Patil, Salihah Ali, Alamdeep Kaur, Meghan Akridge, Davida Eppes, James Paarlberg, Amitabh Parashar, Nabil Jarmukli

Open Access Original Article

Impact of Myocardial Fibrosis on Cardiovascular Structure, Function and Functional Status in Heart Failure with Preserved Ejection Fraction

Gavin A. Lewis, Anna Rosala-Hallas, Susanna Dodd, Erik B. Schelbert, Simon G. Williams, Colin Cunnington, Theresa McDonagh, Christopher A. Miller

Open Access Original Article

Analogue Mean Systemic Filling Pressure: a New Volume Management Approach During Percutaneous Left Ventricular Assist Device Therapy

Konstantin Yastrebov, Laurencie Brunel, Hugh S. Paterson, Zoe A. Williams, Chris S. Burrows, Innes K. Wise, Benjamin M. Robinson, Paul G. Bannon

Open Access Short Communication

Investigation into the Health Effects of Reduced Chymase Function Using Predicted Loss-of-Function Mutations in CMA1

Zammy Fairhurst-Hunter, Robin G. Walters, Alexander Zink, Kuang Lin, Yu Guo, Canqing Yu, Jun Lv, Liming Li, Daniel F. Freitag, Zhengming Chen, Iona Y. Millwood

Correction

Correction to: The Role of Angiogenesis and Arteriogenesis in Myocardial Infarction and Coronary Revascularization

Cristiano Spadaccio, Antonio Nenna, David Rose, Francesco Piccirillo, Annunziata Nusca, Francesco Grigioni, Massimo Chello, Gus J. Vlahakes

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.